We are live on ! Find out more
ALZN icon

Alzamend Neuro
ALZN

14 hedge funds and large institutions have $132K invested in Alzamend Neuro in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

85% more capital invested

Capital invested by funds: $71.2K → $132K (+$60.6K)

56% more funds holding

Funds holding: 9 → 14 (+5)

0.11% more ownership

Funds ownership: 0.12% → 0.23% (+0.11%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$47.9K
2
Citadel Advisors
Citadel Advisors
Florida
+$43.8K
3
Renaissance Technologies
Renaissance Technologies
New York
+$21.4K
4
VF
Virtu Financial
New York
+$18.2K
5
UBS Group
UBS Group
Switzerland
+$1.17K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$28.1K
2
TRCT
Tower Research Capital (TRC)
New York
-$5.4K
3
Wells Fargo
Wells Fargo
California
-$1.69K
4
CA
CoreCap Advisors
Michigan
-$1.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$38.9K +$47.9K +3,727 New
Citadel Advisors
2
Citadel Advisors
Florida
$35.5K +$43.8K +3,404 New
Truist Financial
3
Truist Financial
North Carolina
$18K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$17.4K +$21.4K +1,667 New
VF
5
Virtu Financial
New York
$15K +$18.2K +1,413 New
BlackRock
6
BlackRock
New York
$4.61K – – –
UBS Group
7
UBS Group
Switzerland
$951 +$1.17K +91 New
Citigroup
8
Citigroup
New York
$631 +$771 +60 New
TRCT
9
Tower Research Capital (TRC)
New York
$450 -$5.4K -420 -91%
Bank of America
10
Bank of America
North Carolina
$158 +$39 +3 +25%
AWM
11
Activest Wealth Management
Florida
$23 – – –
HIA
12
Harbor Investment Advisory
Maryland
$23 – – –
SS
13
SBI Securities
Japan
$21 +$26 +2 New
Osaic Holdings
14
Osaic Holdings
Arizona
$7 +$13 +1 New
CSB
15
City State Bank
Iowa
$5 – – –
Morgan Stanley
16
Morgan Stanley
New York
$3 – – –
PA
17
Parallel Advisors
California
$3 – – –
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
– -$28.1K -1,845 Closed
Wells Fargo
19
Wells Fargo
California
– -$1.69K -111 Closed
CA
20
CoreCap Advisors
Michigan
– -$1.2K -79 Closed

ALZN Hedge Fund Activity: Q4 2024 in Review

14 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Alzamend Neuro (ALZN) for Q4 2024, worth a combined $132K — up 85% from $71.2K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ALZN positions and 3 closed out — a net gain of 5 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $47.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $28.1K sold.

  • 14 institutional investors held Alzamend Neuro (ALZN) as of Q4 2024, up from 9 in Q3 2024.
  • Funds reported $132K of Alzamend Neuro stock for Q4 2024, up 85% quarter-over-quarter.
  • 8 funds opened new Alzamend Neuro positions in Q4 2024 and 3 closed out, a net change of +5 holders.
  • The largest Alzamend Neuro buyer in Q4 2024 was Geode Capital Management, an estimated $47.9K added.
  • The largest Alzamend Neuro seller in Q4 2024 was Susquehanna International Group, an estimated $28.1K sold.

Based on aggregated 13F filings for Q4 2024.